Skip to content

Kymera Therapeutics, Inc.

biopharmaceutical company

KYMR Nasdaq SEC CIK 1815442

Follow Kymera Therapeutics Weekly email: filings, results, news

News

5 stories filed under Kymera Therapeutics, grouped into ongoing threads

Call

Thread · 2 stories

Kymera Therapeutics, Inc. 2026 Q2 - Results - Earnings Call Presentation

Earnings 50 d ago

Kymera Therapeutics, Inc. (KYMR) Q2 2026 Earnings Call Transcript

Earnings 50 d ago

More coverage

Kymera Therapeutics at Stifel forum: faster path for lead drug

Markets 9 h ago

Piper Sandler reiterates Kymera Therapeutics stock rating at $140

Markets 1 d ago

Kymera Therapeutics chief legal officer Adams disposes of $744k in KYMR stock

Markets 20 d ago

Profile

Headquarters: WATERTOWN, MA, United States
Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)
Website: kymeratx.com

Peers

Where this page comes from

Profile · SEC EDGAR, Wikidata

News · 5 stories clustered from the RSS aggregator